2,3'-Bipyridine-2',4',5',6'-d4, 1,2,3,6-tetrahydro-1-nitroso-
CAS:1020719-69-0
Formula:
C10H7D4N3O
Color and Shape:
Solid
Molecular weight:
193.2385
Ref: IN-DA0006KB
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
YC/T 184-2004 Labelled Nitrosamines Mixture 690 100 µg/mL in Dichloromethane
Controlled ProductColor and Shape:
Mixture
Ref: 04-A50000690DI
1ml | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-A-386001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
(R,S)-N-Nitroso Anatabine-2,4,5,6-d4 (0.1 mg/mL in Methanol)
Controlled ProductCAS:1020719-69-0
Formula:
C10H4H7N3O
Color and Shape:
Single Solution
Molecular weight:
193.24
Ref: TR-KIT0780
5x1ml | 500.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
(R,S)-N-Nitroso Anatabine-2,4,5,6-d4
Controlled ProductCAS:1020719-69-0
Formula:
C10H4H7N3O
Color and Shape:
Light Yellow
Molecular weight:
193.24
Ref: TR-N524752
5mg | 2,679.00 € | ||
500µg | 410.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
(R,S)-N-Nitroso Anatabine-2,4,5,6-d4 (40ug/ml in Acetonitrile)
Controlled ProductCAS:1020719-69-0
Formula:
C10H4H7N3O
Color and Shape:
Colourless
Molecular weight:
193.24
Ref: TR-KIT4158
1x10ml | 539.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
(R,S)-N-Nitroso Anatabine-2,4,5,6-d4 (1 mg/mL in Methanol)
CAS:1020719-69-0
Formula:
C10H4H7N3O
Color and Shape:
Single Solution
Molecular weight:
193.24
Ref: TR-KIT1840
1x1ml | 1,547.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
(R,S)-N-Nitroso Anatabine-2,4,5,6-d4 (Major)
CAS:1020719-69-0
Applications Labelled (R,S)-N-Nitroso Anatabine (N524750). (R,S)-N-Nitroso Anatabin is a metabolite of tobacco, a specific N-nitrosamines. …
Formula:
C10H7D4N3O
Color and Shape:
Light Yellow
Molecular weight:
193.24
Ref: TR-N524753
1mg | Discontinued | Request information | |
10mg | Discontinued | Request information |